Vimarsana
Biggest News Aggregation in the World

Robertn Fried News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robertn Fried. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robertn Fried Today - Breaking & Trending Today

Rudy Tackles 4K UHD SteelBook with Dolby Vision/Atmos & New Director's Cut on November 14 - Vimarsana News

Rudy Tackles 4K UHD SteelBook with Dolby Vision/Atmos & New Director's Cut on November 14

'The latest news on all things 4k Ultra HD, Blu-ray and Gear'

So I Married an Axe Murderer Takes a Swing At 4K Ultra HD Blu-ray on July 25 - Vimarsana News

So I Married an Axe Murderer Takes a Swing At 4K Ultra HD Blu-ray on July 25

'The latest news on all things 4k Ultra HD, Blu-ray and Gear'

ChromaDex (NASDAQ:CDXC) PT Lowered to $7.00 at HC Wainwright - Vimarsana News

ChromaDex (NASDAQ:CDXC) PT Lowered to $7.00 at HC Wainwright

ChromaDex (NASDAQ:CDXC – Get Rating) had its price objective cut by stock analysts at HC Wainwright from $8.00 to $7.00 in a note issued to investors on Tuesday, The Fly reports. HC Wainwright’s price target indicates a potential upside of 266.49% from the stock’s current price. CDXC has been the topic of several other research […]

ChromaDex Co. (NASDAQ:CDXC) Expected to Announce Quarterly Sales of $18.87 Million - Vimarsana News

ChromaDex Co. (NASDAQ:CDXC) Expected to Announce Quarterly Sales of $18.87 Million

Brokerages expect ChromaDex Co. (NASDAQ:CDXC – Get Rating) to announce sales of $18.87 million for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for ChromaDex’s earnings, with the highest sales estimate coming in at $21.00 million and the lowest estimate coming in at $16.07 million. ChromaDex posted sales of $17.70 […]

ChromaDex (NASDAQ:CDXC) Upgraded to Hold by Zacks Investment Research - Vimarsana News

ChromaDex (NASDAQ:CDXC) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of ChromaDex (NASDAQ:CDXC – Get Rating) from a sell rating to a hold rating in a research report report published on Wednesday, Zacks.com reports. According to Zacks, “ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food […]